Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

100 results about "Prevalent Nephrotic Syndrome" patented technology

Pre-existing nephrotic syndrome.

Traditional Chinese medicine composition for treating nephritic syndrome and application method thereof

The invention discloses a traditional Chinese medicine composition for treating nephritic syndrome, which comprises the following components in parts by weight: 10-30 parts of common achyranthes herb, 5-15 parts of houttuynia, 5-15 parts of barbed skullcap herb, 5-15 parts of motherwort, 5-15 parts of plantain herb, 10-30 parts of cogongrass rhizome, 0.5-1.5 parts of juncus communis, 2-15 parts of forsythia, 4-12 parts of rhizoma alismatis, 1-3 parts of herba elephantopi, 5-15 parts of raw milk vetch, 5-15 parts of radix rehmanniae, 5-15 parts of radix adenophorae, 5-15 parts of prunella vulgaris, 5-15 parts of ramulus euonymi, 2-6 parts of atractylodes rhizome, 2-6 parts of phellodendron bark, 4-12 parts of honeysuckle, 4-12 parts of eclipta, 4-12 parts of cortex dictamni radicis, 1-3 parts of cicada slough, 2-6 parts of fried gardenia, 2-6 parts of fried scutellaria, 2-6 parts of grifola, 2-6 parts of poria, 1-3 parts of ginger peel, 1-3 parts of radix sileris, 1-3 parts of licorice root, 4-12 parts of rhizoma anemarrhenae, 4-12 parts of skunk bugbane and 4-12 parts of bupleurum. The traditional Chinese medicine composition disclosed by the invention has the functions of nourishing the lung, spleen and kidney yang, treating tri-jiao syndrome and promoting blood circulation, can not cause injury and pain to human bodies, and has the advantages of wide medicinal resources and no toxic side effects.
Owner:杨萍萍

Application of salvianolic acid A in independent-medicine or multiple-medicine-combined nephrotic syndrome treatment

ActiveCN105687178AGood triglyceride lowering effectReduce resistanceOrganic active ingredientsUrinary disorderHormonal resistancePrevalent Nephrotic Syndrome
The invention relates to application of traditional Chinese medicine effective components, mainly relates to application of salvianolic acid A in independent-medicine or multiple-medicine-combined nephrotic syndrome treatment, discloses application of salvianolic acid A or medicinal salt of salvianolic acid A in independent-medicine or multiple-medicine-combined nephrotic syndrome treatment, and aims at introducing salvianolic acid A to nephrotic syndrome treatment and treating the hormonal resistance type nephrotic syndrome through an independent medicine or multi-medicine combination. By introducing salvianolic acid A, the curative effect of glucocorticoid is enhanced, salvianolic acid A is beneficial to clinical reasonable application of glucocorticoid, the treatment effectiveness of glucocorticoid is improved, and hormone toxicity and hormone resistance are reduced; meanwhile, the action characteristics and molecular mechanism of salvianolic acid A are made clear, reliable foundation is provided for treating the nephrotic syndrome through salvianolic acid A, new routes are opened up for researching new treatment medicine, and certain foundation is established for development of traditional Chinese medicine of the same type.
Owner:SUZHOU LEINA PHARMA RES DEV

Ultrafine powder of HMG-CoA reductase inhibitor and preparation method of ultrafine powder

The invention relates to ultrafine powder of an HMG-CoA reductase inhibitor and a preparation method of the ultrafine powder. The HMG-CoA reductase inhibitor is mainly used for heterozygous familial and non-familial hyperlipidemia and can also be used for hypercholesteremia caused by type-2 diabetes and nephrotic syndrome. The preparation method of the ultrafine powder of the HMG-CoA reductase inhibitor includes: in a homogeneous solution containing the HMG-CoA reductase inhibitor, applying ultrasonic wave of 10kHz-500kHz in frequency, of 1mW-5000W in power and 0.1mW / cm<2>-500W / cm<2> to quickly obtain HMG-CoA reductase inhibitor crystals; subjecting the HMG-CoA reductase inhibitor crystals to conventional operations such as solid collection, washing and drying to directly obtain the ultrafine powder of the HMG-CoA reductase inhibitor. The ultrafine powder prepared by the method does not contain matrix materials, has the characterisitics of large drug carrying capacity, high dissolving speed and easiness in realizing higher bioavailability, stability and safety and the like, meets needs on improving bioavailability of drug, lowering drug dosage and reducing adverse reaction and is wider in application range.
Owner:无锡朗立药业有限公司 +1

Traditional Chinese medicinal preparation for treating nephritis

The invention relates to a traditional Chinese medicinal preparation for treating nephritis and is characterized in that the traditional Chinese medicinal preparation is prepared from the following raw materials of: by weight, pseudostellaria root, heydyotis, achyranthes bidentata bl, lily, Chinese yam, nequim, Alisma Orientalis, tortoiseshell, anemarrhena, Cortex moutan, phellodendron, cicada slough, lumbricus, muscardine silkworm, couchgrass root, broom cypress fruit, silver flower, Japanese honeysuckle stem, pseudo-ginseng, pyrrosia leaf, a pair of Gekko gecko and 200 Prednisone tablets. The traditional Chinese medicinal preparation is prepared by the following steps of: uniformly mixing the above dried Chinese herbal medicines, crushing, grinding the Prednisone tablets into a powder, mixing the Chinese herbal medicinal powders with the Prednisone powder, sieving through a sieve of 180 meshes, and packaging into capsules. The traditional Chinese medicinal preparation for treating nephritis has good efficacy of supplementing qi and nourishing yin and stimulating blood circulation to end stasis and diuresis, and has good curative effects of treating nephritis, edema of nephrotic syndrome, proteinuria and the like. At present, the traditional Chinese medicinal preparation has been used to treat a thousand of patients with nephritis and nephrotic syndrome during the recovery period. The effective rate reaches 95.2% and the cure rate reaches 90%.
Owner:张成林

Medicament for treating nephritic syndromes

InactiveCN101810796AReasonable ratioTo achieve the purpose of treating nephrotic syndromeUrinary disorderPlant ingredientsFood regulationSide effect
The invention relates to the technical field of pure Chinese medicaments, in particular to a medicament for treating nephritic syndromes. The medicament solves the problems of the conventional medicament for treating the nephritic syndromes has side effects on the severe nephritic syndromes. The medicament for treating the nephritic syndromes is prepared from the following raw materials in part by weight: 20 to 40 parts of plantain seed, 20 to 40 parts of corn stigma, 20 to 40 parts of lalang grass rhizome, 20 to 40 parts of salix leaf, 5 to 15 parts of areca peel, and 5 to 15 parts of exocarpium citri leiocarpae. The medicament has the effects of promoting urination, eliminating venom in vivo, promoting circulation of qi, dispersing swelling and expelling toxicity, and freeing qi of internal organs so as to fulfill the aim of treating the nephritic syndrome by combining modern pharmacological research achievements according to pathogenesis of the nephritic syndrome, selecting the Chinese medicaments from natural Chinese medicinal raw materials, and reasonably mixing the Chinese medicaments in a certain proportion. The medicament can achieve the effects of treating both symptoms and root causes, and has the advantages of quick response and short course of treatment by combining oral administration, acupuncture and food regulation.
Owner:吴贵成
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products